Lv11
100 积分 2025-10-17 加入
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
2小时前
已完结
Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non–Small Cell Lung Cancer
11天前
已完结
Efficacy, safety, and exploratory biomarker analysis of rechallenge with immune checkpoint inhibitors combined with anlotinib in previously treated advanced non-small cell lung cancer
1个月前
已关闭
Intratumoral Expression of a Composite B Cell / CD8 T Cell Biomarker Stratifies Overall Survival by Circulating Tumor DNA Status and Benefit From Adjuvant Immunotherapy in High-Risk Muscle-Invasive Urothelial Carcinoma
2个月前
已关闭
Clinicopathologic features, concurrent genomic alterations, and clinical outcomes of patients with KRAS G12D mutations in resected lung adenocarcinoma
2个月前
已完结
BRCA and Breast Cancer-Related High-Penetrance Genes
2个月前
已完结
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
3个月前
已完结
Factors associated with the use of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study
3个月前
已完结
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
4个月前
已完结
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer
7个月前
已完结
皖公网安备34019202002308
